Novo Nordisk, OpenAI partner on drug development

Summary

Novo Nordisk said its OpenAI partnership will apply AI across drug discovery, manufacturing, and operations by the end of 2026.

Why this matters

The deal shows how major drugmakers are using AI beyond research to manufacturing and business operations. It also comes as Novo Nordisk and Eli Lilly compete in obesity and diabetes treatments and in AI-led drug development.

Novo Nordisk said April 14 that it formed a strategic partnership with OpenAI to apply artificial intelligence across drug discovery, manufacturing, supply chains, and commercial operations.

The Danish drugmaker said the goal is to speed research, analyze large biological datasets, and bring treatments to patients sooner. Pilot programs are starting immediately, and full integration into core workflows is expected by the end of 2026.

“This partnership is one important step in positioning Novo Nordisk to lead in the next era of healthcare,” the company said.

According to Novo Nordisk’s press release, the partnership will use AI to identify drug candidates, support manufacturing efficiency, and improve supply chain and commercial operations. OpenAI will also help train Novo Nordisk’s global workforce in AI literacy.

Novo Nordisk said the arrangement includes data governance and human oversight to support ethical and compliant use. OpenAI CEO Sam Altman said AI can help “people live better, longer lives” in life sciences.

The agreement comes as Novo Nordisk and Eli Lilly compete in obesity and diabetes treatments. Novo Nordisk built its business around glucagon-like peptide-1, or GLP-1, medicines, but the gap with Eli Lilly has narrowed.

Eli Lilly won U.S. approval earlier this month for its weight-loss pill Foundayo. Novo Nordisk launched an oral version of Wegovy in January 2026. Analysts forecast the global weight-loss drug market could top $100 billion in annual revenue over the next decade.

Eli Lilly also announced a partnership with Insilico Medicine in March 2026 to develop and commercialize AI-discovered medicines, according to Euronews.

Novo Nordisk said it plans to combine OpenAI’s models with its existing AI capabilities, including the Gefion AI supercomputer and internal scientific expertise.

  • NC panel backs jail mental evaluations for suspects

    North Carolina lawmakers recommended telehealth mental evaluations in jails for suspects already in custody, instead of ERs.

    Full story +

  • Duplin drug investigation leads to 4 arrests

    Authorities said a Duplin County drug investigation led to four arrests and seizures of drugs, firearms, and nearly $10,000 in cash.

    Full story +

  • Kihei man charged in laser strikes on FBI aircraft

    The Federal Aviation Administration said in 2023 that laser strikes on aircraft are a significant public safety threat. The FBI said Hawaii has consistently had one of the highest incident rates in the country.

    Full story +

  • Manteo man charged in 1990 New Jersey killing

    Robert William McCaffrey Jr., 54, was charged with first-degree murder, first-degree kidnapping, and second-degree burglary in connection with the June 1990 homicide of Lisa Marie McBride.

    Full story +

  • N.C. Supreme Court weighs retiree health benefits case

    The case has been in the courts for more than a decade.

    Full story +

  • U.N. report: Haiti gang gains slowed, threat remains

    U.N. rights chief said last month 5,519 people were killed in Haiti between March 2025 and mid-January 2026 and at least 3,497 of those deaths resulted from anti-gang operations, including both civilians and gang members.

    Full story +

  • Strikes in northern Gaza kill 10, including toddler

    The deaths came despite a ceasefire in the Gaza war that took effect Oct. 10. Israel and Hamas have repeatedly accused each other of violating the truce.

    Full story +

  • Iran seeks war compensation ahead of U.S. talks

    Iranian officials signaled they did not plan major concessions in talks with Washington, including on nuclear enrichment. Ebrahim Rezaei, spokesman for parliament’s National Security and Foreign Policy Commission, wrote that the two-week ceasefire announced last week should not be extended.

    Full story +

  • Sudan calls Berlin conference interference in affairs

    The meeting brought together governments, aid agencies, and civil society groups, but excluded both fighting parties. It followed similar conferences in London and Paris over the past two years that did not produce a diplomatic breakthrough.

    Full story +

  • Iranian woman detained in France returns to Iran

    Her return came a week after French citizens Cecile Kohler, 41, and Jacques Paris, 72, arrived in France after being held in Iran for more than three years.

    Full story +